Navigation Links
SyntheZyme Wins Second National Science Foundation Grant to Commercialize Promising Biopesticide
Date:5/17/2011

/p>

SyntheZyme has also made significant progress in developing a highly durable, recyclable bioplastic made from yeast and fatty acids from plant oils. This unique material may be a suitable substitute for polyethylene used in disposable gloves, food packaging films and films for ice, trash and produce bags.

SyntheZyme is jointly owned by Dr. Gross and NYU-Poly. The company is also part of the New York City Accelerator for a Clean and Renewable Economy (NYC-ACRE), NYU-Poly's small-business incubator fostering clean technology and renewable energy companies in New York City.

About Polytechnic Institute of New York University

Polytechnic Institute of New York University (formerly Polytechnic University), an affiliate of New York University, is a comprehensive school of engineering, applied sciences, technology and research, and is rooted in a 157-year tradition of invention, innovation and entrepreneurship: i-squared-e. The institution, founded in 1854, is the nation's second-oldest private engineering school. In addition to its main campus in New York City at MetroTech Center in downtown Brooklyn, it also offers programs at sites throughout the region and around the globe. Globally, NYU-Poly has programs in Israel, China and is an integral part of NYU's campus in Abu Dhabi. For more information, visit www.poly.edu.

About SyntheZyme

SyntheZyme is a privately-held sustainable chemical company commercializing the technology developed in the laboratories of Professor Richard A. Gross at the Polytechnic Institute of NYU. Dr. Gross is the Herman F. Mark Professor of Polymer Science and head of the Center for Biocatalysis and Bio-processing of Macromolecules at NYU-Poly. Located in Brooklyn, N.Y., SyntheZyme uses the understanding of biocatalysis to replace petrochemical based industrial chemicals with biobased and biodegradable alternatives. Focus
'/>"/>

SOURCE Polytechnic Institute of New York University
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Tapestry Reports Second Quarter 2007 Results
3. Callisto Reports on Second-Quarter 2007 Milestones
4. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
11. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... MONTREAL , 21. November 2014 ... hat heute bekannt gegeben, dass ... – EMA) die Kennzeichnung als Orphan-Medizinprodukt ... Produktkandidat des Unternehmens zur Behandlung von ... eine seltene, stark beeinträchtigende genetische Krankheit, ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... , Chief Executive Officer, will be presenting at the 26 ... York Palace Hotel in New York . ... at 2:00 PM ET. In addition, Mr. Krakauer and ... for separate one-on-one meetings during the day. ...
(Date:11/21/2014)... -- Depomed, Inc. (NASDAQ: DEPO ) today announced that ... Annual Healthcare Conference in New York City . ... for 8:00 am EST (5:00 am PST) on Tuesday December 2, ... accessed via the Investor Relations page of the Depomed website at ... for 30 days on the company,s website. About ...
Breaking Medicine Technology:Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2
... IBM ) scientists have developed a flexible, non-contact ... researchers and pathologists to investigate critical tissue samples ... Flickr Photos: http://www.flickr.com/photos/ibm_research_zurich/sets/72157628678347543 ... pathology to detect disease markers in a patient,s ...
... CITY, Calif., Jan. 12, 2012  Cardica, Inc. (Nasdaq: ... in its European clinical trial of the MicroCutter XPRESS™ ... the XPRESS 30 did not perform satisfactorily in thicker ... requires modifications to the product. There have been no ...
Cached Medicine Technology:MADE IN IBM LABS: New Silicon Probe Assists in Disease Diagnostics and Drug Discovery 2MADE IN IBM LABS: New Silicon Probe Assists in Disease Diagnostics and Drug Discovery 3MADE IN IBM LABS: New Silicon Probe Assists in Disease Diagnostics and Drug Discovery 4Cardica Provides Update on MicroCutter™ Program 2Cardica Provides Update on MicroCutter™ Program 3Cardica Provides Update on MicroCutter™ Program 4
(Date:11/21/2014)... Florida (PRWEB) November 21, 2014 TruDenta, ... chronic headaches and other jaw-related symptoms, has ... seeking relief from chronic head pain, neck pain, TMJ ... , “This year we have seen a 52% increase ... Our network of over 300 doctors and their teams ...
(Date:11/21/2014)... CDT PLUS! 2015 represents the ... everything needed to process dental insurance claims. View ... CDT 2015 codes are mandatory for reporting dental procedures ... 31, 2014. Dental professionals must use HIPAA mandated CDT ... There are significant changes in the CDT coding system ...
(Date:11/21/2014)... MO (PRWEB) November 21, 2014 ... Melancholy Lift, an industry leader in the ... people have significant feelings of sadness and depression ... from traditional pharmaceutical choices. Often, prescription drugs can ... depression. Prescription drugs are expensive and require regular ...
(Date:11/21/2014)... 21, 2014 According to a National ... June 11th, 2014, the inflating system found in certain ... airbag inflates. The force of inflation may cause the ... metal shards may pierce the airbag’s fabric and potentially ... , According to a Bloomberg Business Week article ...
(Date:11/21/2014)... London, UK (PRWEB) November 21, 2014 ... only ISO verified healthcare professional panel, today announced two important ... appointment of Roni DasGupta as President of Market Research, Americas ... Market Research, Europe. , Ms. DasGupta joined M3 ... President and most recently Head of Sales. Roni has ...
Breaking Medicine News(10 mins):Health News:National Rise In Patients Seeking Headache Relief 2Health News:PMIC Announces CDT PLUS! 2015, the Ultimate Coding Reference for Dentists and Oral Surgeons 2Health News:Depression Relief Product Receives Top 5-Star Rating from TopConsumerReviews.com 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2
... of unregulated tobacco products, the World Health Organisation (WHO) ... prevent more than five million deaths each year attributed ... anti-tobacco programmes, especially aimed at adolescent girls, among whom ... use, it finds, also continued to expand most rapidly ...
... public services watchdog, the hospitals in Scotland are failing to ... condition known as ‘Deep vein thrombosis’ (DVT), wherein a blood ... ,An enquiry that was conducted in the cases of ... the failure to diagnose the condition had resulted in the ...
... a doctor, today examined patients at the All India Institute ... end their strike or face termination of service. // ... terminate them from service,' he said when asked about the ... return to work., ,The minister, wearing the doctors' white ...
... The Supreme Court today has issued a notice to ... which a policy decision to implement 27 per cent ... quota issue continuing, the Supreme Court today decided to ... cent reservation to socially and economically backward classes in ...
... the students to end their agitation on the reservation issue. ... so contempt// action can be initiated against the students. ... left "patients at the mercy of God". ,"We ... If they are over-reaching our orders, they are in for ...
... President A P J Abdul Kalam today met representatives ... break the impasse with the students and doctors deciding// ... of agitating medicos, which also included members of AIIMS ... had a 45-minute meeting with Kalam. The medicos presented ...
Cached Medicine News:Health News:Hospitals In Scotland Not Diagnosing DVT Properly 2Health News:Supreme Court Verdict Gives Hope to Striking Medicos 2Health News:Supreme Court Warns Medicos of Contempt Action 2Health News:President Kalam Meets Striking Medicos However Stir to Continue 2
Titanium hemi arthroplasty implant for degenerative and post-traumatic arthritis of first metatarsophalangeal joint....
... Ad-Techs Cueva Cranial Nerve Electrodes ... skull base surgeries. Their patented circumferential ... nerve, and yields high-quality, stable real-time ... with valuable information during the removal ...
... As with all of Ad-Techs products, our Sphenoidal ... quality. They are available in stainless steel or ... or 2.75 inch (70 mm) long, 21 gauge ... electrodes are supplied as kits or sets. You ...
... is a medical device designed to handle ... capability, and archiving demands of the EEG ... framework that helps organize workflow and the ... centralized database and powerful search capability keeps ...
Medicine Products: